Ajay Kaul, MD

Director, Neurogastroenterology and Motility Disorders Program

Academic Affiliations

Professor, UC Department of Pediatrics

Phone 513-636-4415

Fax 513-636-7805

Email ajay.kaul@cchmc.org

MD: Government Medical College, Jabalpur, India, 1986.

Residency: Children's Hospital of Buffalo, Buffalo, NY; The State University of New York, Albany, NY.

Fellowship: Children's Hospital Medical Center, Cincinnati, OH, 1995-1998.

Certification: Pediatrics, 1995; Pediatric Gastroenterology, 1999.

View PubMed Publications

Kraus D, Wong BL, Horn PS, Kaul A. Constipation in Duchenne Muscular Dystrophy: Prevalence, Diagnosis, and Treatment. J Pediatr. 2016.

Warren M, Kaul A, Bove K. Calretinin-immunoreactive hypoinnervation in Down syndrome (DS): report of an infant with very short-segment Hirschsprung disease (vsHD) and comparison to biopsy findings in 20 normal infants and 11 infants with DS and chronic constipation. Pediatr Dev Pathol. 2015 Jul 31.

Martin LJ, Franciosi JP, Collins MH, Abonia JP, Lee JJ, Hommel KA, Varni JW, Grotjan JT, Eby M, He H, Marsolo K, Putnam PE, Garza JM, Kaul A, Wen T, Rothenberg ME. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015 Jun;135(6):1519-1528.

Sherrill JD, Kiran KC, Blanchard C, Stucke EM, Kemme KA, Collins MH, Abonia JP, Putnam PE, Mukkada VA, Kaul A, Kocoshis SA, Kushner JP, Plassard AJ, Karns RA, Dexheimer PJ, Aronow BJ, Rothenberg ME. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun. 2014 Sep;15(6):361-9.

Alexander ES, Martin LJ, Kaul A, Nadeau KC, Noel RJ, Putnam PE, Rothenberg ME, et. al. Twin and Family Studies Reveal Strong Environmental and Weaker Genetic Cues Explaining Heritability of Eosinophilic Esophagitis. J Allergy Clin Immunol. 2014 Nov;134(5):1084-1092.

Woodley FW, Machado RS, Hayes D Jr, Di Lorenzo C, Kaul A, Skaggs B, McCoy K, Patel A, Mousa H. Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis. Dig Dis Sci. 2014 Mar;59(3):623-30.

Rayapudi M, Rajavelu P, Zhu X, Kaul A, Mishra A, et al. Invariant natural killer T-Cell Neutralization is a Possible Novel Therapy for Human Eosinophilic Esophagitis. Clin Transl Immunology. Jan 2014;10:3.

Wen T, Stucke EM, Grotjan TM, Kemme KA, Abonia JP, Putnam PE, Franciosi JP, Garza JM, Kaul A, King EC, Collins MH, Kushner JP, Rothenberg ME. Molecular Diagnosis of Eosinophilic Esophagitis by Gene Expression Profiling. Gastroenterology. 2013 Dec;145(6):1289-99.

Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT; Members of the BCS Task Force. Summary of the national institute of child health and human development-best pharmaceuticals for children act pediatric formulation initiatives workshop-pediatric biopharmaceutics classification system working group. Clin Ther. 2012 Nov;34(11):S11-24.

Furuta GT, Williams K, Kooros K, Kaul A, Panzer R, Coury DL, Fuchs G. Management of constipation in children and adolescents with autism spectrum disorders. Pediatrics. 2012 Nov;130 Suppl 2:S98-S105.